Market Tracker

09/01 9:31am ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.43
Data as of Aug 29
 +0.15 / +11.72%
Today’s Change
1.11
Today|||52-Week Range
3.01
-30.92%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.28
Today’s open1.28
Day’s range1.28 - 1.43
Volume1,013,674
Average volume (3 months)836,025
Market cap$215.4M
Dividend yield--
Data as of 4:01pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CPRXCatalyst Pharmaceuti...+0.08+2.56%
NNVCNanoViricides Inc+0.06+1.55%
CCXIChemoCentryx Inc+0.08+1.59%
OHRPOHR Pharmaceutical I...+0.08+0.98%
Data as of 4:01pm ET, 08/29/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mike M. Goldberg
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts